Skip to content

300858.SZ

Beijing Scitop Bio-tech Co., Ltd.

SZSE · Healthcare · C 制造业 · CN

CNY 13.36
+1.75%
Ask drillr

Year over year

Reported trailing growth

Revenue
+16.2%
EBITDA
—
EBIT
-14.5%
EPS
-7.3%
Free cash flow
+26.4%
Operating cash flow
+16.2%

Forward estimates

Based on analyst estimates

Revenue
—
EBITDA
—
EPS
—

Three-year CAGR

Revenue
-0.3%
EBITDA
-1.4%
EBIT
-6.4%
Net income
-4.9%
EPS
-9.8%
Free cash flow
—

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026